Overview
Efficacy and Safety of Canadá Association in the Treatment of Chronic Pain
Status:
Not yet recruiting
Not yet recruiting
Trial end date:
2028-07-01
2028-07-01
Target enrollment:
0
0
Participant gender:
All
All
Summary
The purpose of this study is to evaluate the efficacy and safety of Canadá association in the treatment of chronic painPhase:
Phase 2Accepts Healthy Volunteers?
NoDetails
Lead Sponsor:
EMSTreatments:
Dipyrone
Tramadol
Criteria
Inclusion Criteria:- Ability to confirm voluntary participation and agree to all trial purposes by signing
and dating the consent form;
- Chronic pain during at least 3 months.
Exclusion Criteria:
- Any clinical and laboratory findings that, in the judgment of the investigator, may
interfere with the safety of participants;
- History of alcohol abuse or illicit drug use;
- Participation in a clinical trial in the year prior to this study;
- Pregnancy or risk of pregnacy and lactating participants;
- Known hypersensitivity to any of the formula compounds.